{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T17:24:13Z","timestamp":1785691453782,"version":"3.56.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:p>In solid tumors, glycolytic cancer or stromal cells export lactates through monocarboxylate transporter (MCT) 4, while oxidative cancer or stromal cells take up lactates as metabolic fuels or signaling molecules through MCT1. CD147 acts as a chaperone of MCT1 or MCT4. Unlike solid tumors, malignant lymphomas have a peculiar tumor microenvironment. To investigate the metabolic phenotype of malignant lymphoma associated with lactate transport, we analyzed immunohistochemical expressions of MCT1, MCT4, and CD147 in 247 cases of various malignant lymphomas. Surprisingly, both MCT1 and MCT4 were diffusely expressed on tumor cell membranes in all cases (11\/11, 100%) of anaplastic lymphoma kinase (ALK) (+) anaplastic large cell lymphoma (ALCL). In contrast, only MCT1 was diffusely expressed in tumor cells of ALK(\u2212) ALCL, as well as in B-cell, natural killer\/T-cell, T-cell, and classic Hodgkin lymphomas. In these lymphomas, MCT4 expression was mostly localized to adjacent stromal cells. The pattern of diffuse membranous MCT1 and partial MCT4 expressions in tumor cells was observed in 1 case each of peripheral T-cell lymphoma (1\/15, 6.7%) and multiple myeloma (1\/34, 2.9%). CD147 was diffusely expressed in all types of lymphoma tumor and\/or stromal cells. In conclusion, ALK(+) ALCL has a unique metabolism showing high coexpression of MCT1 and MCT4 in tumor cells. Because only ALK(+) ALCL overexpresses MCT4, immunostaining for MCT4 together with ALK is very useful for differential diagnosis from ALK(\u2212) ALCL or peripheral T-cell lymphoma. Moreover, dual targeting against MCT1 and MCT4 would be an appropriate therapeutic approach for ALK(+) ALCL.<\/jats:p>","DOI":"10.1097\/pas.0000000000001820","type":"journal-article","created":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T05:38:14Z","timestamp":1633671494000},"page":"241-248","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Coexpression of MCT1 and MCT4 in ALK-positive Anaplastic Large Cell Lymphoma"],"prefix":"10.1097","volume":"46","author":[{"given":"Jung-Woo","family":"Choi","sequence":"first","affiliation":[{"name":"Department of Pathology, Korea University Ansan Hospital, Ansan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngseok","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Pathology, Korea University Anam Hospital, Seoul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunchul","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cha University Ilsan Medical Center, Goyang"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Yee","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Pathology, Korea University Anam Hospital, Seoul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Kee","family":"Min","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Sik","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pathology, Korea University Ansan Hospital, Ansan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,10,7]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"R3-20250608","first-page":"1476","article-title":"Lung cancer: a comparative study of metabolism related protein expression in cancer cells and tumor associated stroma","volume":"6","author":"Koukourakis","year":"2007","journal-title":"Cancer Biol Ther"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.4161\/cc.10.11.15659","article-title":"Evidence for a stromal-epithelial \u201clactate shuttle\u201d in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts","volume":"10","author":"Whitaker-Menezes","year":"2011","journal-title":"Cell Cycle"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"23111","DOI":"10.1074\/jbc.M202487200","article-title":"Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis","volume":"277","author":"Lu","year":"2002","journal-title":"J Biol Chem"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00424-003-1067-2","article-title":"The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond","volume":"447","author":"Halestrap","year":"2004","journal-title":"Pflugers Arch"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"427694","DOI":"10.1155\/2010\/427694","article-title":"Expression of monocarboxylate transporters 1, 2, and 4 in human tumours and their association with CD147 and CD44","volume":"2010","author":"Pinheiro","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"9030","DOI":"10.1074\/jbc.M511397200","article-title":"The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism","volume":"281","author":"Ullah","year":"2006","journal-title":"J Biol Chem"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1158\/0008-5472.CAN-04-3605","article-title":"Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases","volume":"65","author":"Tang","year":"2005","journal-title":"Cancer Res"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0002-9440(10)64660-3","article-title":"Tumorigenic potential of extracellular matrix metalloproteinase inducer","volume":"158","author":"Zucker","year":"2001","journal-title":"Am J Pathol"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s10585-010-9345-9","article-title":"Co-expression of CD147\/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression","volume":"27","author":"Chen","year":"2010","journal-title":"Clin Exp Metastasis"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/1471-2407-11-312","article-title":"Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer","volume":"11","author":"Pertega-Gomes","year":"2011","journal-title":"BMC Cancer"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"160","DOI":"10.5858\/arpa.2019-0182-RA","article-title":"A practical approach to diagnosis of B-cell lymphomas with diffuse large cell morphology","volume":"144","author":"King","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/sj.onc.1201062","article-title":"ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin\u2019s lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)","volume":"14","author":"Morris","year":"1997","journal-title":"Oncogene"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1038\/onc.2010.505","article-title":"Oncogenic kinase NPM\/ALK induces expression of HIF1alpha mRNA","volume":"30","author":"Marzec","year":"2011","journal-title":"Oncogene"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1158\/0008-5472.CAN-13-2034","article-title":"Blocking lactate export by inhibiting the Myc target MCT1 disables glycolysis and glutathione synthesis","volume":"74","author":"Doherty","year":"2014","journal-title":"Cancer Res"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1182\/blood-2014-08-594507","article-title":"Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma","volume":"125","author":"Weilemann","year":"2015","journal-title":"Blood"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","article-title":"Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma","volume":"123","author":"Iqbal","year":"2014","journal-title":"Blood"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.1038\/sj.onc.1210346","article-title":"Oncogenic tyrosine kinase NPM\/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway","volume":"26","author":"Marzec","year":"2007","journal-title":"Oncogene"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1182\/blood-2013-01-482026","article-title":"Integrated phosphoproteomic and metabolomic profiling reveals NPM-ALK-mediated phosphorylation of PKM2 and metabolic reprogramming in anaplastic large cell lymphoma","volume":"122","author":"McDonnell","year":"2013","journal-title":"Blood"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.celrep.2016.01.057","article-title":"MCT1 modulates cancer cell pyruvate export and growth of tumors that co-express MCT1 and MCT4","volume":"14","author":"Hong","year":"2016","journal-title":"Cell Rep"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"3047.e4","DOI":"10.1016\/j.celrep.2018.11.043","article-title":"Dual Inhibition of the lactate transporters MCT1 and MCT4 is synthetic lethal with metformin due to NAD+ depletion in cancer cells","volume":"25","author":"Benjamin","year":"2018","journal-title":"Cell Rep"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/j.seminoncol.2013.04.016","article-title":"Reverse Warburg effect in a patient with aggressive B-cell lymphoma: is lactic acidosis a paraneoplastic syndrome?","volume":"40","author":"Martinez-Outschoorn","year":"2013","journal-title":"Semin Oncol"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1182\/blood.V122.21.2993.2993","article-title":"Hodgkin lymphoma: metabolic symbiosis between malignant cells and cancer-associated stromal tissue","volume":"122","author":"Sprandio","year":"2013","journal-title":"Blood"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.4161\/cc.26193","article-title":"CD147 regulates the expression of MCT1 and lactate export in multiple myeloma cells","volume":"12","author":"Walters","year":"2013","journal-title":"Cell Cycle"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1186\/1471-2407-12-586","article-title":"GLUT1 expression patterns in different Hodgkin lymphoma subtypes and progressively transformed germinal centers","volume":"12","author":"Hartmann","year":"2012","journal-title":"BMC Cancer"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40164-015-0008-z","article-title":"Lactate, a putative survival factor for myeloma cells, is incorporated by myeloma cells through monocarboxylate transporters 1","volume":"4","author":"Fujiwara","year":"2015","journal-title":"Exp Hematol Oncol"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nm.4128","article-title":"Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity","volume":"22","author":"Eichner","year":"2016","journal-title":"Nat Med"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"534561","DOI":"10.1155\/2009\/534561","article-title":"Severe lactic acidosis in a patient with B-cell lymphoma: a case report and review of the literature","volume":"2009","author":"Chan","year":"2009","journal-title":"Case Rep Med"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/MAJ.0b013e3181c3fdeb","article-title":"Diffuse large B-cell lymphoma in a hepatitis C virus-infected patient presenting with lactic acidosis and hypoglycemia","volume":"339","author":"Keller","year":"2010","journal-title":"Am J Med Sci"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"e502","DOI":"10.1038\/bcj.2016.104","article-title":"Uncovering molecular abnormalities leading to the Warburg effect in primary refractory diffuse large B-cell lymphoma","volume":"6","author":"Soleja","year":"2016","journal-title":"Blood Cancer J"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001820","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T21:03:04Z","timestamp":1749416584000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001820"}},"subtitle":["Diagnostic and Therapeutic Implications"],"short-title":[],"issued":{"date-parts":[[2021,10,7]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001820","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,7]]}}}